OXYCODONE AND ACETAMINOPHEN TABLETS

OXYCODONE AND ACETAMINOPHEN TABLETS was reported 12007 times

OXYCODONE AND ACETAMINOPHEN TABLETS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRIP STRENGTH 39 0.1703
1 VISION ABNORMAL NEONATAL 71 0.1699
2 SWOLLEN JOINT COUNT 30 0.1200
3 NEONATAL HYPOACUSIS 26 0.1088
4 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 10 0.0952
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 185 0.0924
6 SYNOVIAL FLUID ANALYSIS 8 0.0920
7 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 526 0.0809
8 LUPUS VULGARIS 100 0.0794
9 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 44 0.0784
10 MUSCLE INJURY 623 0.0751
11 X-RAY ABNORMAL 131 0.0732
12 DUODENAL ULCER PERFORATION 544 0.0731
13 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 522 0.0728
14 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 48 0.0719
15 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 148 0.0714
16 C-REACTIVE PROTEIN 63 0.0680
17 CHOROIDAL INFARCTION 8 0.0667
18 LEARNING DISABILITY 339 0.0636
19 SWOLLEN JOINT COUNT INCREASED 201 0.0630
20 DISLOCATION OF VERTEBRA 140 0.0613
21 FOLLICULITIS 638 0.0608
22 PORPHYRIA ACUTE 78 0.0544
23 HELICOBACTER INFECTION 557 0.0541
24 FACET JOINT SYNDROME 165 0.0506
25 RHEUMATIC FEVER 218 0.0489
26 PEMPHIGUS 562 0.0449
27 RETINITIS 76 0.0440
28 HAND DEFORMITY 565 0.0430
29 RHEUMATOID FACTOR POSITIVE 223 0.0386
30 DEVELOPMENTAL DELAY 346 0.0383
31 PERIPHERAL VENOUS DISEASE 153 0.0374
32 PRESBYACUSIS 11 0.0357
33 PERICARDITIS 555 0.0330
34 IRRITABLE BOWEL SYNDROME 639 0.0298
35 SYNOVITIS 535 0.0296
36 SUBSTANCE USE DISORDER 83 0.0260
37 C-REACTIVE PROTEIN ABNORMAL 164 0.0255
38 GLOSSODYNIA 566 0.0253
39 DRUG WITHDRAWAL SYNDROME NEONATAL 369 0.0249
40 BONE EROSION 88 0.0249
41 MATERNAL EXPOSURE TIMING UNSPECIFIED 75 0.0199
42 AUTOIMMUNE DISORDER 194 0.0199
43 TENOSYNOVITIS STENOSANS 11 0.0197
44 IMPAIRED HEALING 646 0.0197
45 WOUND 522 0.0187
46 PERSONAL RELATIONSHIP ISSUE 12 0.0179
47 SYNOVIAL DISORDER 8 0.0176
48 PLEURAL THICKENING 12 0.0175
49 TEMPERATURE REGULATION DISORDER 39 0.0175
50 SERONEGATIVE ARTHRITIS 20 0.0175
51 BURSITIS 211 0.0174
52 LIP DRY 155 0.0170
53 BREAST CANCER STAGE III 104 0.0160
54 SYSTEMIC LUPUS ERYTHEMATOSUS 565 0.0159
55 JOINT RANGE OF MOTION DECREASED 210 0.0156
56 WALKING AID USER 100 0.0152
57 GRIP STRENGTH DECREASED 133 0.0151
58 DRUG TOLERANCE DECREASED 42 0.0149
59 WOUND INFECTION 161 0.0147
60 HYPERCHOLESTEROLAEMIA 139 0.0144
61 LOWER RESPIRATORY TRACT INFECTION 654 0.0144
62 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 14 0.0132
63 CONTRAINDICATED PRODUCT ADMINISTERED 397 0.0131
64 PUSTULAR PSORIASIS 45 0.0131
65 TOOTH EROSION 16 0.0131
66 EXOSTOSIS 116 0.0127
67 BONE DEMINERALISATION 13 0.0123
68 BLOOD MAGNESIUM INCREASED 11 0.0122
69 ALLERGY TO CHEMICALS 15 0.0120
70 POST-TRAUMATIC STRESS DISORDER 80 0.0119
71 BONE CYST 11 0.0117
72 BLISTER 647 0.0115
73 LOWER LIMB FRACTURE 218 0.0113
74 THERAPEUTIC PRODUCT EFFECT DECREASED 499 0.0111
75 SCIATICA 176 0.0110
76 PLEURAL FIBROSIS 11 0.0108
77 STOMATITIS 651 0.0107
78 PRE-EXISTING CONDITION IMPROVED 67 0.0107
79 FIBROMYALGIA 260 0.0107
80 HIP ARTHROPLASTY 163 0.0106
81 ARTHROPATHY 586 0.0105
82 ILL-DEFINED DISORDER 636 0.0105
83 OBESITY 165 0.0103
84 LUPUS-LIKE SYNDROME 91 0.0100
85 PRESCRIBED OVERDOSE 186 0.0096
86 RASH VESICULAR 46 0.0095
87 DISCOMFORT 573 0.0094
88 INFUSION RELATED REACTION 619 0.0093
89 INFUSION SITE DISCHARGE 16 0.0091
90 HEPATIC ENZYME INCREASED 610 0.0089
91 KNEE ARTHROPLASTY 183 0.0087
92 HYPERPARATHYROIDISM SECONDARY 21 0.0084
93 LIVER INJURY 204 0.0083
94 FOOT DEFORMITY 91 0.0082
95 DISABILITY 162 0.0082
96 NIGHT SWEATS 262 0.0081
97 TYPE 2 DIABETES MELLITUS 272 0.0081
98 GASTROINTESTINAL DISORDER 694 0.0077
99 JOINT DISLOCATION 81 0.0077
100 FOETAL DEATH 39 0.0075
101 SINUSITIS 766 0.0075
102 ECONOMIC PROBLEM 110 0.0073
103 SWELLING 675 0.0072
104 BREAST CANCER STAGE II 60 0.0072
105 PULMONARY FIBROSIS 138 0.0072
106 CATAPLEXY 10 0.0071
107 RED BLOOD CELL SEDIMENTATION RATE INCREASED 77 0.0070
108 SCLERITIS 11 0.0069
109 FOOD ALLERGY 53 0.0069
110 MULTIPLE DRUG OVERDOSE INTENTIONAL 22 0.0068
111 DRUG SCREEN NEGATIVE 12 0.0068
112 CONTUSION 651 0.0068
113 GAIT INABILITY 223 0.0067
114 PREGNANCY 130 0.0065
115 PSORIATIC ARTHROPATHY 262 0.0064
116 JOINT SWELLING 775 0.0064
117 SPINAL FUSION SURGERY 26 0.0064
118 TRANSCRIPTION MEDICATION ERROR 10 0.0064
119 LIVE BIRTH 53 0.0063
120 LOSS OF EMPLOYMENT 19 0.0063
121 GENERAL SYMPTOM 47 0.0063
122 PRODUCT ADMINISTRATION INTERRUPTED 49 0.0062
123 OBSTRUCTIVE SLEEP APNOEA SYNDROME 9 0.0062
124 DEAFNESS NEUROSENSORY 20 0.0061
125 ROAD TRAFFIC ACCIDENT 254 0.0061
126 END STAGE RENAL DISEASE 108 0.0059
127 MYOSITIS 53 0.0059
128 NEPHROGENIC ANAEMIA 27 0.0058
129 HEPATIC CIRRHOSIS 109 0.0058
130 SPONDYLITIS 21 0.0058
131 SLEEP DISORDER 404 0.0057
132 OSTEOSCLEROSIS 9 0.0057
133 OSTEOARTHRITIS 240 0.0057
134 DRUG INTOLERANCE 546 0.0056
135 MUSCLE SPASTICITY 68 0.0055
136 INFECTION 801 0.0055
137 RHEUMATOID ARTHRITIS 625 0.0055
138 DEPENDENCE 294 0.0054
139 BLOOD CHOLESTEROL INCREASED 250 0.0054
140 PERIPHERAL SWELLING 826 0.0054
141 DELIRIUM 183 0.0053
142 INFUSION SITE BRUISING 11 0.0051
143 TENOSYNOVITIS 14 0.0051
144 PLEURITIC PAIN 14 0.0051
145 REBOUND ACID HYPERSECRETION 15 0.0050
146 BACK DISORDER 80 0.0049
147 ESSENTIAL HYPERTENSION 9 0.0049
148 CONGENITAL ANOMALY 38 0.0049
149 FOETAL EXPOSURE DURING PREGNANCY 391 0.0048
150 LIVER DISORDER 211 0.0048
151 CONFUSIONAL STATE 767 0.0047
152 INFUSION SITE REACTION 14 0.0047
153 WITHDRAWAL SYNDROME 196 0.0047
154 EYE INJURY 14 0.0046
155 OEDEMA 249 0.0046
156 WEIGHT FLUCTUATION 48 0.0046
157 INJURY 320 0.0045
158 IMPRISONMENT 8 0.0045
159 MATERNAL EXPOSURE DURING PREGNANCY 401 0.0045
160 COELIAC DISEASE 44 0.0045
161 EAR PAIN 87 0.0045
162 DEVICE INFUSION ISSUE 11 0.0044
163 DRUG DEPENDENCE 705 0.0044
164 CHRONIC KIDNEY DISEASE 329 0.0043
165 NASOPHARYNGITIS 795 0.0043
166 ACCIDENTAL DEATH 8 0.0043
167 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 71 0.0042
168 ABDOMINAL DISCOMFORT 700 0.0042
169 WHEEZING 247 0.0042
170 EAR INFECTION 109 0.0041
171 HYPERSENSITIVITY 760 0.0041
172 ANHEDONIA 106 0.0040
173 RESPIRATORY DISORDER 120 0.0040
174 MUSCULOSKELETAL STIFFNESS 351 0.0040
175 LUNG DISORDER 196 0.0040
176 ULCER HAEMORRHAGE 27 0.0040
177 SHOULDER OPERATION 17 0.0040
178 IMPAIRED GASTRIC EMPTYING 54 0.0040
179 DRUG TOLERANCE 20 0.0039
180 UPPER RESPIRATORY TRACT INFECTION 182 0.0039
181 MUSCULOSKELETAL PAIN 205 0.0039
182 EPIGASTRIC DISCOMFORT 15 0.0038
183 THERAPY NON-RESPONDER 172 0.0038
184 SLEEP APNOEA SYNDROME 73 0.0038
185 IMMUNODEFICIENCY 57 0.0038
186 SPINAL OPERATION 47 0.0038
187 SEASONAL ALLERGY 54 0.0038
188 PRESCRIBED UNDERDOSE 76 0.0038
189 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 180 0.0037
190 CREPITATIONS 11 0.0037
191 OSTEOPOROSIS 151 0.0037
192 MACULOPATHY 13 0.0037
193 INFUSION SITE HAEMORRHAGE 12 0.0036
194 RHEUMATOID NODULE 10 0.0036
195 INFLAMMATION 184 0.0036
196 OXYGEN SATURATION ABNORMAL 10 0.0035
197 CANCER PAIN 9 0.0035
198 SEDATION 92 0.0035
199 JOINT STIFFNESS 91 0.0035
200 ALOPECIA 680 0.0035
201 EXPOSURE TO TOXIC AGENT 11 0.0034
202 NECK SURGERY 8 0.0034
203 MOBILITY DECREASED 245 0.0034
204 DRUG DIVERSION 21 0.0034
205 WEIGHT INCREASED 761 0.0034
206 SKIN ABRASION 16 0.0034
207 INFUSION SITE SWELLING 21 0.0033
208 VASCULAR DEVICE INFECTION 15 0.0033
209 CRANIOCEREBRAL INJURY 10 0.0033
210 OSTEOPENIA 50 0.0033
211 HAEMATOLOGICAL INFECTION 8 0.0033
212 BODY TEMPERATURE INCREASED 66 0.0032
213 TREATMENT FAILURE 264 0.0032
214 INTENTIONAL PRODUCT USE ISSUE 278 0.0032
215 INFUSION SITE PRURITUS 10 0.0032
216 AMNESIA 204 0.0031
217 PSYCHOLOGICAL TRAUMA 27 0.0031
218 BACK INJURY 34 0.0031
219 CUSHINGOID 10 0.0031
220 COMA SCALE ABNORMAL 9 0.0031
221 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 53 0.0031
222 FREQUENT BOWEL MOVEMENTS 83 0.0031
223 HAEMOGLOBIN INCREASED 14 0.0031
224 NECK INJURY 9 0.0031
225 RADICULOPATHY 8 0.0030
226 SYNOVIAL CYST 14 0.0030
227 INADEQUATE ANALGESIA 25 0.0029
228 DRY MOUTH 236 0.0029
229 SPINAL STENOSIS 12 0.0029
230 PARANASAL SINUS DISCOMFORT 11 0.0029
231 SOMNAMBULISM 19 0.0029
232 DERMATITIS CONTACT 33 0.0029
233 INSURANCE ISSUE 44 0.0029
234 SPRUE-LIKE ENTEROPATHY 14 0.0028
235 SURGERY 166 0.0028
236 GENERAL PHYSICAL HEALTH DETERIORATION 327 0.0028
237 FACIAL BONES FRACTURE 10 0.0028
238 FLUID RETENTION 141 0.0028
239 HIP SURGERY 15 0.0028
240 ANTINUCLEAR ANTIBODY POSITIVE 9 0.0028
241 ASTHMA 312 0.0028
242 TOOTH INFECTION 36 0.0027
243 BLEPHAROSPASM 17 0.0027
244 LYME DISEASE 9 0.0027
245 MEDICATION ERROR 150 0.0027
246 MULTIPLE ALLERGIES 21 0.0027
247 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 11 0.0026
248 KNEE OPERATION 26 0.0026
249 INFUSION SITE PAIN 34 0.0026
250 C-REACTIVE PROTEIN INCREASED 96 0.0026
251 INTERVERTEBRAL DISC DEGENERATION 24 0.0026
252 RESPIRATORY ARREST 71 0.0026
253 COMPLETED SUICIDE 214 0.0026
254 SUSPECTED SUICIDE 12 0.0026
255 LABORATORY TEST ABNORMAL 75 0.0025
256 ANXIETY 721 0.0025
257 DENTAL CARIES 28 0.0025
258 DEPRESSION 571 0.0025
259 NEPHROLITHIASIS 114 0.0025
260 BLOOD PHOSPHORUS DECREASED 9 0.0025
261 BONE DENSITY DECREASED 77 0.0025
262 MIGRAINE 234 0.0024
263 ALCOHOL USE 9 0.0024
264 RIB FRACTURE 50 0.0024
265 DRUG TOXICITY 33 0.0024
266 PAIN 1484 0.0024
267 LUMBAR VERTEBRAL FRACTURE 11 0.0024
268 TENDERNESS 25 0.0024
269 PYREXIA 828 0.0024
270 QUALITY OF LIFE DECREASED 32 0.0024
271 ONYCHOMADESIS 10 0.0024
272 INFUSION SITE ERYTHEMA 20 0.0024
273 ARTHRALGIA 980 0.0024
274 TONGUE DISCOMFORT 10 0.0024
275 ARTHRITIS 185 0.0023
276 THYROID MASS 9 0.0023
277 OESOPHAGEAL DISORDER 9 0.0023
278 ANKLE FRACTURE 36 0.0023
279 BENIGN PROSTATIC HYPERPLASIA 12 0.0023
280 FOOT FRACTURE 44 0.0023
281 WHITE BLOOD CELL COUNT INCREASED 89 0.0023
282 FAILURE TO THRIVE 12 0.0023
283 NAIL DISORDER 20 0.0023
284 RESPIRATORY DEPRESSION 28 0.0023
285 NIGHTMARE 79 0.0023
286 HANGOVER 8 0.0023
287 PRURITUS 866 0.0023
288 DEFORMITY 21 0.0022
289 ACUTE RESPIRATORY FAILURE 43 0.0022
290 MALNUTRITION 25 0.0022
291 RECTAL HAEMORRHAGE 96 0.0022
292 MENTAL STATUS CHANGES 62 0.0022
293 LIGAMENT SPRAIN 22 0.0022
294 HYPOAESTHESIA 333 0.0022
295 CHEST PAIN 409 0.0022
296 DYSPEPSIA 217 0.0022
297 CARDIOMEGALY 27 0.0022
298 ABDOMINAL HERNIA 10 0.0022
299 ARTHRITIS INFECTIVE 10 0.0022
300 DRUG SCREEN POSITIVE 17 0.0021
301 PERFORMANCE STATUS DECREASED 10 0.0021
302 POST PROCEDURAL COMPLICATION 41 0.0021
303 DECREASED ACTIVITY 23 0.0021
304 SNORING 8 0.0021
305 INCORRECT DRUG ADMINISTRATION RATE 9 0.0021
306 MENISCUS INJURY 13 0.0021
307 URTICARIA 354 0.0021
308 HYPERTENSION 447 0.0021
309 LEFT VENTRICULAR HYPERTROPHY 9 0.0021
310 NEURALGIA 51 0.0021
311 ENDOMETRIOSIS 10 0.0021
312 SENSITIVITY TO WEATHER CHANGE 11 0.0021
313 IMPAIRED QUALITY OF LIFE 30 0.0021
314 PANCREATITIS 110 0.0021
315 TOOTH LOSS 43 0.0021
316 ATELECTASIS 20 0.0021
317 DIVERTICULUM INTESTINAL 9 0.0021
318 LIVER FUNCTION TEST INCREASED 44 0.0020
319 ORAL INFECTION 8 0.0020
320 ABDOMINAL PAIN UPPER 420 0.0020
321 INTENTIONAL DOSE OMISSION 58 0.0020
322 FLANK PAIN 19 0.0020
323 TASTE DISORDER 41 0.0020
324 RASH 879 0.0020
325 FACIAL PAIN 18 0.0020
326 MULTIPLE DRUG OVERDOSE 10 0.0020
327 ABDOMINAL TENDERNESS 10 0.0020
328 EXPOSURE DURING PREGNANCY 125 0.0020
329 DECREASED APPETITE 457 0.0020
330 JOINT INJURY 42 0.0020
331 UPPER LIMB FRACTURE 39 0.0020
332 HYPERAESTHESIA 16 0.0019
333 COLITIS ULCERATIVE 87 0.0019
334 OEDEMA PERIPHERAL 236 0.0019
335 ATTENTION DEFICIT HYPERACTIVITY DISORDER 8 0.0019
336 EMOTIONAL DISTRESS 230 0.0019
337 DYSPNOEA 1075 0.0019
338 KIDNEY INFECTION 37 0.0019
339 JOINT EFFUSION 13 0.0019
340 LIMB OPERATION 9 0.0019
341 COMPRESSION FRACTURE 10 0.0019
342 FATIGUE 1452 0.0019
343 BRONCHITIS 138 0.0019
344 MEMORY IMPAIRMENT 256 0.0019
345 DIZZINESS POSTURAL 18 0.0019
346 BACK PAIN 431 0.0019
347 RESPIRATORY TRACT INFECTION 48 0.0018
348 PRODUCT SUBSTITUTION ISSUE 106 0.0018
349 NORMAL NEWBORN 10 0.0018
350 INTERVERTEBRAL DISC PROTRUSION 40 0.0018
351 DIABETIC NEUROPATHY 9 0.0018
352 TOOTH FRACTURE 20 0.0018
353 RHINITIS ALLERGIC 8 0.0018
354 GALLBLADDER DISORDER 32 0.0018
355 ROTATOR CUFF SYNDROME 23 0.0018
356 DRUG USE DISORDER 15 0.0018
357 MUSCULAR WEAKNESS 202 0.0018
358 WRONG PRODUCT ADMINISTERED 12 0.0018
359 INFUSION SITE EXTRAVASATION 11 0.0018
360 PRODUCT USE ISSUE 332 0.0018
361 CONDITION AGGRAVATED 536 0.0018
362 ULCER 28 0.0018
363 PERONEAL NERVE PALSY 10 0.0018
364 LOWER GASTROINTESTINAL HAEMORRHAGE 13 0.0018
365 HYPERHIDROSIS 226 0.0018
366 WRIST FRACTURE 21 0.0018
367 ENCEPHALOPATHY 43 0.0017
368 OVERDOSE 377 0.0017
369 SKIN LACERATION 19 0.0017
370 DRUG LEVEL ABOVE THERAPEUTIC 8 0.0017
371 MUSCLE SPASMS 320 0.0017
372 LIMB INJURY 47 0.0017
373 METABOLIC DISORDER 10 0.0017
374 UMBILICAL HERNIA 8 0.0017
375 GLOMERULAR FILTRATION RATE DECREASED 21 0.0017
376 INSOMNIA 455 0.0017
377 FEELING OF BODY TEMPERATURE CHANGE 10 0.0017
378 UPPER-AIRWAY COUGH SYNDROME 14 0.0017
379 ORAL PAIN 38 0.0017
380 SKIN INFECTION 19 0.0017
381 ADVERSE EVENT 156 0.0017
382 NODULE 22 0.0017
383 EYE INFECTION 19 0.0017
384 ACUTE KIDNEY INJURY 256 0.0017
385 APNOEA 13 0.0017
386 TOOTH ABSCESS 17 0.0017
387 PRODUCT FORMULATION ISSUE 11 0.0017
388 GAIT DISTURBANCE 319 0.0017
389 BONE LOSS 25 0.0017
390 HUMERUS FRACTURE 8 0.0017
391 BRAIN FOG 26 0.0017
392 GASTROOESOPHAGEAL REFLUX DISEASE 132 0.0016
393 NERVE COMPRESSION 15 0.0016
394 CARDIOMYOPATHY 24 0.0016
395 HYPERVOLAEMIA 8 0.0016
396 THERAPY CESSATION 83 0.0016
397 FOOT OPERATION 8 0.0016
398 HYSTERECTOMY 14 0.0016
399 BLADDER DISORDER 16 0.0016
400 RED BLOOD CELL COUNT DECREASED 46 0.0016
401 WEIGHT DECREASED 448 0.0016
402 OSTEOMYELITIS 29 0.0016
403 SPUTUM DISCOLOURED 15 0.0016
404 DYSPHORIA 8 0.0016
405 CARPAL TUNNEL SYNDROME 22 0.0016
406 PARAESTHESIA 247 0.0016
407 PNEUMONIA 507 0.0016
408 SINUS DISORDER 31 0.0016
409 INTENTIONAL PRODUCT MISUSE 137 0.0016
410 ILLNESS 161 0.0016
411 PULMONARY TOXICITY 11 0.0016
412 HAND FRACTURE 11 0.0016
413 SINUS TACHYCARDIA 22 0.0015
414 RENAL INJURY 46 0.0015
415 BLOOD POTASSIUM INCREASED 25 0.0015
416 HYPOVOLAEMIA 9 0.0015
417 PAIN IN EXTREMITY 452 0.0015
418 FEELING HOT 94 0.0015
419 MALABSORPTION 8 0.0015
420 ELECTROCARDIOGRAM ABNORMAL 12 0.0015
421 NERVE INJURY 17 0.0015
422 RENAL FAILURE 202 0.0015
423 CONSTIPATION 331 0.0015
424 ANKYLOSING SPONDYLITIS 20 0.0015
425 CHOLECYSTITIS 18 0.0015
426 PRODUCTIVE COUGH 72 0.0015
427 GASTROENTERITIS VIRAL 27 0.0015
428 TOOTHACHE 27 0.0015
429 BREAST MASS 10 0.0015
430 INJECTION SITE DISCHARGE 8 0.0015
431 MUSCULOSKELETAL CHEST PAIN 23 0.0015
432 ANAL ABSCESS 8 0.0015
433 THERAPY INTERRUPTED 106 0.0015
434 POSTOPERATIVE WOUND INFECTION 10 0.0015
435 GROIN PAIN 13 0.0015
436 SPINAL OSTEOARTHRITIS 13 0.0015
437 VISUAL IMPAIRMENT 183 0.0015
438 SUBSTANCE ABUSE 12 0.0015
439 DECUBITUS ULCER 12 0.0015
440 EAR DISCOMFORT 15 0.0015
441 VOMITING 687 0.0015
442 MULTIPLE FRACTURES 24 0.0015
443 FAECALOMA 8 0.0015
444 ADVERSE DRUG REACTION 131 0.0015
445 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 9 0.0015
446 HEADACHE 913 0.0015
447 MUSCULOSKELETAL DISCOMFORT 25 0.0015
448 SPINAL PAIN 17 0.0014
449 HYPERKERATOSIS 8 0.0014
450 IMPAIRED WORK ABILITY 31 0.0014
451 THERAPEUTIC RESPONSE UNEXPECTED 65 0.0014
452 ILEUS 18 0.0014
453 LARGE INTESTINE POLYP 10 0.0014
454 NECROSIS 8 0.0014
455 DRUG-INDUCED LIVER INJURY 45 0.0014
456 BLOOD SODIUM DECREASED 27 0.0014
457 RENAL TUBULAR NECROSIS 14 0.0014
458 BLOOD CALCIUM DECREASED 16 0.0014
459 ASTHENIA 535 0.0014
460 CANDIDA INFECTION 24 0.0014
461 FEELING JITTERY 27 0.0014
462 DELUSION 22 0.0014
463 HAEMATOCRIT DECREASED 28 0.0014
464 DIVERTICULUM 10 0.0014
465 PRODUCT DISTRIBUTION ISSUE 13 0.0014
466 CONJUNCTIVITIS 26 0.0014
467 SPINAL FRACTURE 28 0.0014
468 BRAIN INJURY 14 0.0014
469 UNRESPONSIVE TO STIMULI 36 0.0014
470 HYPOACUSIS 60 0.0014
471 SKIN ULCER 36 0.0014
472 INCOHERENT 9 0.0014
473 HEAD INJURY 44 0.0014
474 FURUNCLE 11 0.0014
475 NASAL DISCOMFORT 11 0.0014
476 TUBULOINTERSTITIAL NEPHRITIS 26 0.0014
477 RENAL CYST 11 0.0014
478 RASH ERYTHEMATOUS 66 0.0014
479 PRODUCT DISPENSING ERROR 30 0.0014
480 PRODUCT DOSE OMISSION IN ERROR 39 0.0014
481 CYST 17 0.0014
482 LOCALISED INFECTION 33 0.0014
483 BLOOD POTASSIUM DECREASED 41 0.0014
484 APPETITE DISORDER 9 0.0014
485 TEMPERATURE INTOLERANCE 14 0.0014
486 SKIN LESION 37 0.0013
487 HERNIA 26 0.0013
488 NECK PAIN 75 0.0013
489 ACCIDENT 16 0.0013
490 VITAMIN D DEFICIENCY 13 0.0013
491 HOSPITALISATION 204 0.0013
492 FRACTURE 25 0.0013
493 IMPAIRED DRIVING ABILITY 15 0.0013
494 NOCTURIA 16 0.0013
495 CARDIO-RESPIRATORY ARREST 55 0.0013
496 MICTURITION URGENCY 15 0.0013
497 FALL 437 0.0013
498 DRUG ABUSE 109 0.0013
499 TOOTH DISORDER 29 0.0013
500 DRUG ABUSER 8 0.0013
501 SMALL INTESTINAL OBSTRUCTION 16 0.0013
502 PHARYNGITIS STREPTOCOCCAL 14 0.0013
503 CONCUSSION 10 0.0013
504 SCOLIOSIS 8 0.0013
505 BIPOLAR DISORDER 14 0.0013
506 PELVIC FRACTURE 10 0.0013
507 DYSPNOEA EXERTIONAL 48 0.0013
508 AFFECTIVE DISORDER 10 0.0013
509 DIARRHOEA 817 0.0013
510 BLOOD IRON DECREASED 15 0.0013
511 NAUSEA 1000 0.0013
512 BLOOD ALBUMIN DECREASED 10 0.0013
513 SINUS CONGESTION 17 0.0013
514 BLOOD PRESSURE ABNORMAL 25 0.0013
515 POOR VENOUS ACCESS 13 0.0013
516 URINARY TRACT INFECTION 213 0.0012
517 DRUG DISPENSING ERROR 19 0.0012
518 MUSCLE DISORDER 10 0.0012
519 MAJOR DEPRESSION 9 0.0012
520 POST PROCEDURAL INFECTION 10 0.0012
521 GASTROINTESTINAL INFECTION 11 0.0012
522 CHOLECYSTECTOMY 14 0.0012
523 PHOTOPHOBIA 23 0.0012
524 DRUG WITHDRAWAL SYNDROME 107 0.0012
525 MENTAL DISORDER 53 0.0012
526 OROPHARYNGEAL DISCOMFORT 11 0.0012
527 MASS 17 0.0012
528 ARTHROPOD BITE 9 0.0012
529 HAIR DISORDER 10 0.0012
530 BLOOD URINE PRESENT 23 0.0012
531 CARDIAC ARREST 100 0.0012
532 PSORIASIS 158 0.0012
533 PULMONARY MASS 18 0.0012
534 ARTERIOSCLEROSIS CORONARY ARTERY 8 0.0012
535 INCREASED TENDENCY TO BRUISE 11 0.0012
536 LEFT VENTRICULAR DYSFUNCTION 8 0.0012
537 CYSTITIS 38 0.0012
538 CLOSTRIDIUM DIFFICILE INFECTION 26 0.0012
539 DIVERTICULITIS 33 0.0012
540 ABSCESS 19 0.0012
541 MALAISE 521 0.0012
542 DISORIENTATION 47 0.0012
543 HYPERSOMNIA 34 0.0012
544 COLITIS ISCHAEMIC 8 0.0012
545 FEEDING DISORDER 24 0.0012
546 HIP FRACTURE 38 0.0012
547 NEOPLASM PROGRESSION 41 0.0012
548 ACIDOSIS 9 0.0012
549 RETCHING 25 0.0012
550 HYPERLIPIDAEMIA 14 0.0012
551 PRODUCT USE IN UNAPPROVED INDICATION 289 0.0012
552 PAIN IN JAW 33 0.0012
553 CARDIAC OPERATION 10 0.0012
554 ONYCHOCLASIS 8 0.0012
555 SNEEZING 26 0.0012
556 CHOLELITHIASIS 38 0.0012
557 LYMPHOEDEMA 8 0.0012
558 ABDOMINAL PAIN 269 0.0012
559 ADRENAL INSUFFICIENCY 14 0.0012
560 PROCEDURAL PAIN 32 0.0012
561 BONE DISORDER 21 0.0012
562 CELLULITIS 58 0.0011
563 UNEVALUABLE EVENT 87 0.0011
564 RESPIRATORY SYNCYTIAL VIRUS INFECTION 10 0.0011
565 URINE OUTPUT DECREASED 10 0.0011
566 CARDIAC DISORDER 107 0.0011
567 FUNGAL INFECTION 38 0.0011
568 NASAL CONGESTION 67 0.0011
569 NEUROPATHY PERIPHERAL 108 0.0011
570 RESPIRATORY TRACT CONGESTION 18 0.0011
571 HEPATIC STEATOSIS 21 0.0011
572 GOUT 20 0.0011
573 HERPES ZOSTER 64 0.0011
574 HOSPICE CARE 11 0.0011
575 MUSCLE TIGHTNESS 18 0.0011
576 BLOOD PRESSURE INCREASED 169 0.0011
577 DEVICE RELATED INFECTION 17 0.0011
578 THROMBOCYTOPENIA 123 0.0011
579 RESTLESS LEGS SYNDROME 20 0.0011
580 ESCHERICHIA INFECTION 9 0.0011
581 ACCIDENTAL OVERDOSE 40 0.0011
582 FULL BLOOD COUNT DECREASED 22 0.0011
583 EMPHYSEMA 11 0.0011
584 DRUG INEFFECTIVE 1436 0.0011
585 SOMNOLENCE 219 0.0011
586 HYPOTHERMIA 11 0.0011
587 INFLUENZA 121 0.0011
588 HYPOPHOSPHATAEMIA 8 0.0011
589 ORAL DISCOMFORT 15 0.0011
590 HAEMORRHOIDS 21 0.0011
591 BONE PAIN 63 0.0011
592 HEAD DISCOMFORT 19 0.0011
593 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 56 0.0011
594 DIZZINESS 534 0.0011
595 HALLUCINATION, AUDITORY 17 0.0011
596 NO THERAPEUTIC RESPONSE 13 0.0011
597 BEDRIDDEN 14 0.0011
598 PRODUCT DOSE OMISSION ISSUE 312 0.0011
599 PULMONARY HYPERTENSION 22 0.0011
600 SPINAL DISORDER 10 0.0011
601 HYPERCALCAEMIA 13 0.0011
602 VITAMIN D DECREASED 9 0.0011
603 WHITE BLOOD CELL COUNT DECREASED 114 0.0011
604 TROPONIN INCREASED 8 0.0011
605 LEUKOCYTOSIS 19 0.0010
606 HOT FLUSH 79 0.0010
607 HAIR COLOUR CHANGES 13 0.0010
608 TOOTH EXTRACTION 13 0.0010
609 BLOOD MAGNESIUM DECREASED 9 0.0010
610 MUSCLE STRAIN 9 0.0010
611 MADAROSIS 12 0.0010
612 THROMBOSIS 83 0.0010
613 BODY HEIGHT DECREASED 11 0.0010
614 MUSCLE ATROPHY 13 0.0010
615 PERIPHERAL COLDNESS 14 0.0010
616 DECREASED IMMUNE RESPONSIVENESS 10 0.0010
617 URINARY RETENTION 34 0.0010
618 HYPOPHAGIA 26 0.0010
619 COVID-19 PNEUMONIA 12 0.0010
620 UPPER GASTROINTESTINAL HAEMORRHAGE 17 0.0010
621 SUICIDE ATTEMPT 61 0.0010
622 SUICIDAL IDEATION 92 0.0010
623 HYPOTENSION 201 0.0010
624 PHARMACEUTICAL PRODUCT COMPLAINT 26 0.0010
625 SENSORY DISTURBANCE 16 0.0010
626 HYPOXIA 35 0.0010
627 BLOOD COUNT ABNORMAL 15 0.0010
628 RENAL DISORDER 46 0.0010
629 PULMONARY CONGESTION 13 0.0010
630 TOXICITY TO VARIOUS AGENTS 166 0.0010
631 HAEMOGLOBIN DECREASED 101 0.0010
632 INTESTINAL OBSTRUCTION 37 0.0010
633 PNEUMONIA BACTERIAL 9 0.0010
634 OCULAR DISCOMFORT 11 0.0010
635 PANCREATITIS ACUTE 22 0.0010
636 PARALYSIS 14 0.0010
637 POLYURIA 8 0.0010
638 HAIR TEXTURE ABNORMAL 13 0.0010
639 FEMUR FRACTURE 30 0.0010
640 PULMONARY ARTERIAL HYPERTENSION 14 0.0010
641 PRODUCT DOSE OMISSION 63 0.0010
642 EMBOLISM 8 0.0010
643 BLOOD PRESSURE DECREASED 64 0.0010
644 INTERNAL HAEMORRHAGE 11 0.0010
645 SEPSIS 107 0.0010
646 POLLAKIURIA 40 0.0010
647 INTENTIONAL DRUG MISUSE 20 0.0010
648 ARTERIOSCLEROSIS 9 0.0010
649 ATRIAL SEPTAL DEFECT 8 0.0010
650 DEHYDRATION 127 0.0010
651 PERICARDIAL EFFUSION 22 0.0010
652 ELECTROLYTE IMBALANCE 11 0.0009
653 HAEMATEMESIS 24 0.0009
654 URINARY INCONTINENCE 28 0.0009
655 POST PROCEDURAL HAEMORRHAGE 11 0.0009
656 CLOSTRIDIUM DIFFICILE COLITIS 10 0.0009
657 HUNGER 13 0.0009
658 HEREDITARY ANGIOEDEMA 10 0.0009
659 RENAL IMPAIRMENT 78 0.0009
660 PARANOIA 16 0.0009
661 HIATUS HERNIA 12 0.0009
662 DYSSTASIA 27 0.0009
663 CARDIAC MURMUR 8 0.0009
664 CATARACT 55 0.0009
665 BLOOD PRESSURE SYSTOLIC INCREASED 18 0.0009
666 EPISTAXIS 69 0.0009
667 OROPHARYNGEAL PAIN 85 0.0009
668 PULMONARY OEDEMA 41 0.0009
669 TINNITUS 42 0.0009
670 RHINORRHOEA 59 0.0009
671 THINKING ABNORMAL 17 0.0009
672 ORAL CANDIDIASIS 12 0.0009
673 ACTIVITIES OF DAILY LIVING IMPAIRED 18 0.0009
674 GASTROINTESTINAL PAIN 10 0.0009
675 CARDIAC FAILURE CONGESTIVE 73 0.0009
676 OXYGEN SATURATION DECREASED 51 0.0009
677 LYMPHOCYTE COUNT DECREASED 16 0.0009
678 DYSURIA 33 0.0009
679 BLOOD UREA INCREASED 15 0.0009
680 GASTRIC ULCER 17 0.0009
681 PRODUCT PHYSICAL ISSUE 18 0.0009
682 BLOOD CREATININE INCREASED 58 0.0009
683 PHARYNGITIS 11 0.0009
684 HEART RATE IRREGULAR 20 0.0009
685 ACUTE HEPATIC FAILURE 12 0.0009
686 HAEMATURIA 30 0.0009
687 THERAPEUTIC RESPONSE DECREASED 53 0.0009
688 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 62 0.0009
689 PROSTATIC SPECIFIC ANTIGEN INCREASED 12 0.0009
690 SKIN FISSURES 17 0.0009
691 EYE PAIN 49 0.0009
692 MUSCLE TWITCHING 20 0.0009
693 IRON DEFICIENCY ANAEMIA 8 0.0009
694 LOSS OF CONSCIOUSNESS 111 0.0009
695 OFF LABEL USE 755 0.0009
696 TREATMENT NONCOMPLIANCE 47 0.0009
697 TRANSFUSION 9 0.0009
698 NEPHROPATHY 8 0.0009
699 ERECTILE DYSFUNCTION 22 0.0009
700 DRUG EFFECT DECREASED 46 0.0009
701 OSTEONECROSIS 28 0.0009
702 ATRIAL FIBRILLATION 83 0.0009
703 INCONTINENCE 9 0.0009
704 FEELING ABNORMAL 204 0.0009
705 DEPRESSED MOOD 45 0.0009
706 FULL BLOOD COUNT ABNORMAL 9 0.0009
707 RENAL PAIN 9 0.0008
708 STAPHYLOCOCCAL INFECTION 28 0.0008
709 VENTRICULAR TACHYCARDIA 14 0.0008
710 MULTIPLE ORGAN DYSFUNCTION SYNDROME 24 0.0008
711 HYPOKALAEMIA 39 0.0008
712 DRY EYE 42 0.0008
713 THIRST 15 0.0008
714 SEROTONIN SYNDROME 16 0.0008
715 AFFECT LABILITY 8 0.0008
716 ADVERSE REACTION 11 0.0008
717 SINUS BRADYCARDIA 8 0.0008
718 PULMONARY THROMBOSIS 9 0.0008
719 PLATELET COUNT DECREASED 87 0.0008
720 DISTURBANCE IN ATTENTION 44 0.0008
721 TREMOR 135 0.0008
722 DYSPHAGIA 77 0.0008
723 DRUG EFFECT LESS THAN EXPECTED 12 0.0008
724 RASH MACULO-PAPULAR 18 0.0008
725 HEART RATE INCREASED 80 0.0008
726 INTERNATIONAL NORMALISED RATIO INCREASED 23 0.0008
727 BACTERIAL INFECTION 15 0.0008
728 ORTHOSTATIC HYPOTENSION 14 0.0008
729 PNEUMONIA ASPIRATION 20 0.0008
730 OVARIAN CYST 8 0.0008
731 HYPERKALAEMIA 28 0.0008
732 EATING DISORDER 17 0.0008
733 BALANCE DISORDER 69 0.0008
734 HEART RATE DECREASED 28 0.0008
735 INTENTIONAL OVERDOSE 51 0.0008
736 METASTASES TO BONE 13 0.0008
737 HYPOMAGNESAEMIA 11 0.0008
738 SCAB 9 0.0008
739 TACHYCARDIA 70 0.0008
740 DISSEMINATED INTRAVASCULAR COAGULATION 11 0.0008
741 NEUTROPHIL COUNT INCREASED 8 0.0008
742 EUPHORIC MOOD 8 0.0008
743 INITIAL INSOMNIA 8 0.0008
744 CHILLS 91 0.0008
745 ABDOMINAL DISTENSION 81 0.0008
746 LIMB DISCOMFORT 24 0.0008
747 CHOKING 15 0.0008
748 ANGER 26 0.0008
749 LETHARGY 44 0.0008
750 MYALGIA 130 0.0008
751 COVID-19 134 0.0008
752 AGEUSIA 19 0.0008
753 SKIN DISCOLOURATION 35 0.0008
754 LACRIMATION INCREASED 23 0.0008
755 COUGH 213 0.0008
756 IMMUNE SYSTEM DISORDER 10 0.0008
757 RASH PRURITIC 41 0.0008
758 FEELING COLD 21 0.0008
759 ABDOMINAL PAIN LOWER 19 0.0008
760 BLOOD PRESSURE FLUCTUATION 18 0.0007
761 ANAEMIA 143 0.0007
762 SKIN DISORDER 25 0.0007
763 COGNITIVE DISORDER 35 0.0007
764 PRODUCT AVAILABILITY ISSUE 17 0.0007
765 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 134 0.0007
766 POOR QUALITY SLEEP 16 0.0007
767 SKIN HAEMORRHAGE 11 0.0007
768 GASTROINTESTINAL HAEMORRHAGE 62 0.0007
769 PLEURAL EFFUSION 45 0.0007
770 PRODUCT TASTE ABNORMAL 10 0.0007
771 VERTIGO 45 0.0007
772 ASPIRATION 8 0.0007
773 HYPOAESTHESIA ORAL 11 0.0007
774 TENDON RUPTURE 9 0.0007
775 RESPIRATORY FAILURE 53 0.0007
776 FLATULENCE 41 0.0007
777 GASTRITIS 19 0.0007
778 AGITATION 53 0.0007
779 VIRAL INFECTION 24 0.0007
780 PLASMA CELL MYELOMA 28 0.0007
781 DYSARTHRIA 27 0.0007
782 HALLUCINATION 54 0.0007
783 APHONIA 10 0.0007
784 PHARYNGEAL OEDEMA 11 0.0007
785 SEPTIC SHOCK 31 0.0007
786 MOUTH ULCERATION 15 0.0007
787 CHROMATURIA 16 0.0007
788 DEPRESSED LEVEL OF CONSCIOUSNESS 28 0.0007
789 MITRAL VALVE INCOMPETENCE 8 0.0007
790 MENTAL IMPAIRMENT 17 0.0007
791 SCAR 12 0.0007
792 MULTIPLE SCLEROSIS RELAPSE 48 0.0007
793 EYE SWELLING 26 0.0007
794 IRRITABILITY 42 0.0007
795 THROAT IRRITATION 31 0.0007
796 COMPLICATION ASSOCIATED WITH DEVICE 10 0.0007
797 SPEECH DISORDER 36 0.0007
798 SEIZURE 79 0.0007
799 SPLENOMEGALY 8 0.0007
800 HAEMOPTYSIS 19 0.0007
801 COLD SWEAT 12 0.0007
802 INCREASED APPETITE 13 0.0007
803 DIABETES MELLITUS INADEQUATE CONTROL 12 0.0007
804 MALIGNANT MELANOMA 9 0.0007
805 COLON CANCER 10 0.0007
806 DIABETES MELLITUS 51 0.0007
807 ELECTROCARDIOGRAM QT PROLONGED 24 0.0007
808 DEEP VEIN THROMBOSIS 43 0.0007
809 CRYING 24 0.0007
810 COAGULOPATHY 11 0.0007
811 NERVOUSNESS 34 0.0007
812 LYMPHOMA 10 0.0006
813 GENERALISED OEDEMA 8 0.0006
814 FAECES DISCOLOURED 14 0.0006
815 MIDDLE INSOMNIA 12 0.0006
816 BURNING SENSATION 45 0.0006
817 GASTRIC DISORDER 22 0.0006
818 BASAL CELL CARCINOMA 10 0.0006
819 SWOLLEN TONGUE 20 0.0006
820 RENAL FAILURE ACUTE 27 0.0006
821 OCULAR HYPERAEMIA 30 0.0006
822 INFLUENZA LIKE ILLNESS 52 0.0006
823 PULMONARY EMBOLISM 60 0.0006
824 NEOPLASM MALIGNANT 42 0.0006
825 CORONARY ARTERY DISEASE 19 0.0006
826 PARAESTHESIA ORAL 9 0.0006
827 EPILEPSY 19 0.0006
828 LYMPHADENOPATHY 22 0.0006
829 HYPOKINESIA 9 0.0006
830 FLUID OVERLOAD 9 0.0006
831 HAEMATOMA 16 0.0006
832 GASTROENTERITIS 9 0.0006
833 UNDERDOSE 45 0.0006
834 CHEST DISCOMFORT 63 0.0006
835 COMA 29 0.0006
836 SARS-COV-2 TEST POSITIVE 8 0.0006
837 BLOOD ALKALINE PHOSPHATASE INCREASED 15 0.0006
838 SKIN CANCER 13 0.0006
839 HYPERGLYCAEMIA 22 0.0006
840 SWELLING FACE 39 0.0006
841 PALPITATIONS 70 0.0006
842 HYPOTHYROIDISM 19 0.0006
843 MOVEMENT DISORDER 19 0.0006
844 EYE IRRITATION 34 0.0006
845 DEATH 506 0.0006
846 MALIGNANT NEOPLASM PROGRESSION 60 0.0006
847 THYROID DISORDER 9 0.0006
848 HEPATOTOXICITY 13 0.0006
849 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 32 0.0006
850 CENTRAL NERVOUS SYSTEM LESION 8 0.0006
851 TENDONITIS 9 0.0006
852 EJECTION FRACTION DECREASED 9 0.0006
853 MUSCULOSKELETAL DISORDER 11 0.0006
854 DIPLOPIA 15 0.0006
855 THERAPY PARTIAL RESPONDER 9 0.0006
856 PANIC ATTACK 21 0.0006
857 ERYTHEMA 118 0.0006
858 COORDINATION ABNORMAL 8 0.0006
859 PRODUCT USE COMPLAINT 9 0.0006
860 SYNCOPE 57 0.0006
861 BLOOD TEST ABNORMAL 8 0.0006
862 HALLUCINATION, VISUAL 12 0.0006
863 MOOD SWINGS 18 0.0006
864 MULTIPLE SCLEROSIS 27 0.0006
865 ORAL HERPES 11 0.0006
866 APHASIA 17 0.0006
867 DRUG INTERACTION 89 0.0006
868 LEUKOPENIA 28 0.0006
869 ABNORMAL BEHAVIOUR 22 0.0006
870 PRURITUS GENERALISED 12 0.0006
871 HAEMORRHAGE 58 0.0006
872 DRY SKIN 74 0.0006
873 COLITIS 21 0.0006
874 PALLOR 15 0.0006
875 MYOCARDIAL INFARCTION 96 0.0005
876 EYE DISORDER 18 0.0005
877 PRODUCT PRESCRIBING ERROR 13 0.0005
878 HAEMATOCHEZIA 30 0.0005
879 RESPIRATORY DISTRESS 15 0.0005
880 ACUTE MYOCARDIAL INFARCTION 16 0.0005
881 AGGRESSION 27 0.0005
882 DEAFNESS 14 0.0005
883 PRESYNCOPE 13 0.0005
884 HYPOCALCAEMIA 10 0.0005
885 ASPARTATE AMINOTRANSFERASE INCREASED 28 0.0005
886 INJECTION SITE BRUISING 42 0.0005
887 LACTIC ACIDOSIS 17 0.0005
888 VISION BLURRED 72 0.0005
889 PRODUCT QUALITY ISSUE 71 0.0005
890 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 12 0.0005
891 MOOD ALTERED 14 0.0005
892 METASTASES TO LIVER 9 0.0005
893 BRADYCARDIA 27 0.0005
894 CYANOSIS 8 0.0005
895 DRUG ERUPTION 9 0.0005
896 MELAENA 11 0.0005
897 TRANSAMINASES INCREASED 11 0.0005
898 RESTLESSNESS 18 0.0005
899 INJECTION SITE URTICARIA 12 0.0005
900 ALANINE AMINOTRANSFERASE INCREASED 30 0.0005
901 EMOTIONAL DISORDER 15 0.0005
902 BLOOD CREATINE PHOSPHOKINASE INCREASED 14 0.0005
903 CARDIAC FAILURE 39 0.0005
904 DRUG LEVEL INCREASED 8 0.0005
905 EXPIRED PRODUCT ADMINISTERED 16 0.0005
906 HYPONATRAEMIA 27 0.0005
907 DRUG DOSE OMISSION 79 0.0005
908 SKIN EXFOLIATION 40 0.0005
909 HEMIPARESIS 8 0.0005
910 FLUSHING 48 0.0005
911 METABOLIC ACIDOSIS 15 0.0005
912 DYSKINESIA 19 0.0005
913 NEUTROPHIL COUNT DECREASED 19 0.0005
914 DEMENTIA 13 0.0005
915 DISEASE PROGRESSION 55 0.0005
916 RASH MACULAR 16 0.0005
917 HYPOGLYCAEMIA 22 0.0005
918 THERAPEUTIC RESPONSE SHORTENED 15 0.0005
919 FEBRILE NEUTROPENIA 30 0.0005
920 VISUAL ACUITY REDUCED 15 0.0005
921 ABASIA 11 0.0004
922 PSYCHOTIC DISORDER 13 0.0004
923 DEVICE DISLOCATION 19 0.0004
924 CEREBROVASCULAR ACCIDENT 73 0.0004
925 DYSPHONIA 25 0.0004
926 TRANSIENT ISCHAEMIC ATTACK 14 0.0004
927 PRODUCT PRESCRIBING ISSUE 9 0.0004
928 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 83 0.0004
929 ASCITES 12 0.0004
930 DYSGEUSIA 30 0.0004
931 HEPATIC FUNCTION ABNORMAL 15 0.0004
932 BLOOD GLUCOSE INCREASED 75 0.0004
933 GLYCOSYLATED HAEMOGLOBIN INCREASED 10 0.0004
934 SHOCK 9 0.0004
935 DRUG ADMINISTRATION ERROR 12 0.0004
936 LIP SWELLING 13 0.0004
937 PRODUCT PREPARATION ERROR 8 0.0004
938 EXPOSURE VIA SKIN CONTACT 10 0.0004
939 DRUG EFFECT INCOMPLETE 14 0.0004
940 NERVOUS SYSTEM DISORDER 12 0.0004
941 DERMATITIS 8 0.0004
942 PANCREATIC CARCINOMA 11 0.0004
943 BLOOD GLUCOSE DECREASED 18 0.0004
944 FEAR 10 0.0004
945 EXTRA DOSE ADMINISTERED 15 0.0004
946 HEPATIC FAILURE 11 0.0004
947 CEREBRAL HAEMORRHAGE 13 0.0004
948 RHABDOMYOLYSIS 15 0.0004
949 EYE PRURITUS 12 0.0004
950 HEPATITIS 9 0.0004
951 BLINDNESS 14 0.0003
952 LUNG NEOPLASM MALIGNANT 14 0.0003
953 NEUTROPENIA 46 0.0003
954 PRODUCT ADHESION ISSUE 12 0.0003
955 THROAT TIGHTNESS 9 0.0003
956 PNEUMONITIS 9 0.0003
957 ABNORMAL DREAMS 9 0.0003
958 INJECTION SITE RASH 10 0.0003
959 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 11 0.0003
960 VAGINAL HAEMORRHAGE 14 0.0003
961 ANGINA PECTORIS 9 0.0003
962 DEVICE ISSUE 28 0.0003
963 INCORRECT DOSE ADMINISTERED 71 0.0003
964 SKIN IRRITATION 14 0.0003
965 APPLICATION SITE ERYTHEMA 8 0.0003
966 DERMATITIS ATOPIC 16 0.0003
967 BREAST CANCER FEMALE 8 0.0003
968 INJECTION SITE MASS 11 0.0003
969 INTERSTITIAL LUNG DISEASE 14 0.0003
970 ACNE 21 0.0003
971 ARRHYTHMIA 13 0.0003
972 PANCYTOPENIA 15 0.0003
973 INJECTION SITE PAIN 82 0.0003
974 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 19 0.0003
975 INJECTION SITE PRURITUS 17 0.0003
976 DEVICE LEAKAGE 11 0.0003
977 ANAPHYLACTIC REACTION 14 0.0003
978 INJECTION SITE SWELLING 19 0.0002
979 INJECTION SITE REACTION 16 0.0002
980 DISEASE RECURRENCE 11 0.0002
981 ECZEMA 11 0.0002
982 CONVULSION 12 0.0002
983 INJECTION SITE ERYTHEMA 26 0.0002
984 ANGIOEDEMA 9 0.0002
985 NO ADVERSE EVENT 36 0.0002
986 ACCIDENTAL EXPOSURE TO PRODUCT 20 0.0002
987 INJECTION SITE HAEMORRHAGE 15 0.0002
988 DEVICE MALFUNCTION 12 0.0002
989 BLADDER CANCER 10 0.0002
990 PROSTATE CANCER 13 0.0002
991 DEVICE DIFFICULT TO USE 9 0.0001
992 BREAST CANCER 12 0.0001
993 PRODUCT STORAGE ERROR 10 0.0001